Literature DB >> 11452125

Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation.

S Dupuis1, C Dargemont, C Fieschi, N Thomassin, S Rosenzweig, J Harris, S M Holland, R D Schreiber, J L Casanova.   

Abstract

Interferons (IFN) alpha/beta and gamma induce the formation of two transcriptional activators: gamma-activating factor (GAF) and interferon-stimulated gamma factor 3 (ISGF3). We report a natural heterozygous germline STAT1 mutation associated with susceptibility to mycobacterial but not viral disease. This mutation causes a loss of GAF and ISGF3 activation but is dominant for one cellular phenotype and recessive for the other. It impairs the nuclear accumulation of GAF but not of ISGF3 in heterozygous cells stimulated by IFNs. Thus, the antimycobacterial, but not the antiviral, effects of human IFNs are principally mediated by GAF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11452125     DOI: 10.1126/science.1061154

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  161 in total

Review 1.  Stat proteins and oncogenesis.

Authors:  Jacqueline Bromberg
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 2.  Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways.

Authors:  Fabio Candotti; Luigi Notarangelo; Roberta Visconti; John O'Shea
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 3.  IFNs and STATs in innate immunity to microorganisms.

Authors:  Thomas Decker; Silvia Stockinger; Marina Karaghiosoff; Mathias Müller; Pavel Kovarik
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

4.  Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype.

Authors:  Hye Sun Kuehn; Julie E Niemela; Karthik Sreedhara; Jennifer L Stoddard; Jennifer Grossman; Christian A Wysocki; M Teresa de la Morena; Mary Garofalo; Jingga Inlora; Michael P Snyder; David B Lewis; Constantine A Stratakis; Thomas A Fleisher; Sergio D Rosenzweig
Journal:  Blood       Date:  2017-08-04       Impact factor: 22.113

5.  STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-alpha in the central nervous system.

Authors:  Jianping Wang; Robert D Schreiber; Iain L Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

Review 6.  Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins.

Authors:  Camille A Knosp; James A Johnston
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

7.  The antagonistic effect between STAT1 and Survivin and its clinical significance in gastric cancer.

Authors:  Hao Deng; Hongyan Zhen; Zhengqi Fu; Xuan Huang; Hongyan Zhou; Lijiang Liu
Journal:  Oncol Lett       Date:  2011-09-16       Impact factor: 2.967

8.  Loss of STAT1 from mouse mammary epithelium results in an increased Neu-induced tumor burden.

Authors:  Peter J Klover; William J Muller; Gertraud W Robinson; Ruth M Pfeiffer; Daisuke Yamaji; Lothar Hennighausen
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

9.  Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors.

Authors:  Gary D Luker; Julie L Prior; Jiling Song; Christina M Pica; David A Leib
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 10.  Incomplete penetrance in primary immunodeficiency: a skeleton in the closet.

Authors:  Conor Gruber; Dusan Bogunovic
Journal:  Hum Genet       Date:  2020-02-17       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.